- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03842566
Evaluation of Age-Related Skin Changes
July 16, 2019 updated by: Allergan
Evaluation of Age-Related Skin Changes Using Clinical Probe Measurements and Imaging
This trial is a knowledge study utilizing skin measurement probes that are non-invasive instruments, with negligible risks for the subjects.
No product will be studied.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Villeurbanne, France, 69100
- Dermscan-Pharmascan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
100 female subjects will be included, with at least 10 subjects per age decade
Description
Inclusion Criteria:
- Caucasian subjects with Fitzpatrick skin type II or III.
- Subject agreeing to complete all study required procedures.
- Subject having given freely and expressly her informed consent.
Exclusion Criteria:
- Pregnant or nursing woman or planning a pregnancy during the study.
- Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
- Subject in a social or sanitary establishment.
- Subject participating to another research on human beings or being in an exclusion period for a previous study.
- Subject who underwent tissue augmentation with dermal fillers including HA, calcium hydroxylapatite, autologous fat, mesotherapy, or other cosmetic procedures (eg, face-lift, laser, photomodulation, intense pulsed light, radiofrequency, dermabrasion, chemical peel, liposuction of the thigh, or other ablative procedures) in the face or thigh within 12 months before study entry or was planning to undergo any such treatment during the study.
- Subject who underwent treatment with botulinum toxins in the face or neck within 6 months of study entry or was planning to undergo such treatment during the study.
- Subject who ever received semi-permanent fillers or permanent facial implants (eg, poly-L-lactic acid, polymethylmethacrylate, silicone, expanded polytetrafluoroethylene) anywhere in the face or thigh, or was planning to be implanted with any of these products at any time during the study.
- Subject with current cutaneous inflammatory or infectious processes (eg, acne, herpes), abscess, an unhealed wound, or a cancerous or precancerous lesion on the face or thigh that could interfere with measurements.
- Subject having changed, started or stopped any hormonal treatment or any treatment likely to have an impact on skin condition (over-the-counter or prescription, oral or topical, or anti-wrinkle products on the face), within 30 days prior to enrollment or is planning to begin using such products during the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
20-29 Years Old
|
|
30-39 Years Old
|
|
40-49 Years Old
|
|
50-59 Years Old
|
|
60-69 Years Old
|
|
70-79 Years Old
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Age-related changes in fine lines on the cheek
Time Frame: 4 Months
|
Measured using a 5 point photonumeric scale (Allergan Fine Lines scale) The scale range is 0 to 4, with 0 indicating no fine lines and 4 being the most severe fine lines (greater than 5 superficial lines with crosshatching). |
4 Months
|
|
Age-related changes in skin hydration on the cheek
Time Frame: 4 Months
|
Tissue dielectric constant measurement using MoistureMeter D (Delfin Technologies).
Tissue dielectric constant is expressed as a unitless value that is directly proportional to the amount of water in the tissue.
|
4 Months
|
|
Age-related changes in skin hydration on the cheek
Time Frame: 4 Months
|
Tissue dielectric constant measurement using a Corneometer (Courage & Khazaka).
Tissue dielectric constant is expressed as a unitless value that is directly proportional to the amount of water in the tissue.
|
4 Months
|
|
Age-related changes in skin barrier function on the cheek
Time Frame: 4 Months
|
Transepidermal water loss measurement using an AquaFlux AF100 (Biox Systems Ltd)
|
4 Months
|
|
Age-related changes in skin radiance on the cheek
Time Frame: 4 Months
|
Measurement of light reflection using a Skin-Glossymeter GL200 (Courage & Khazaka)
|
4 Months
|
|
Age-related changes in skin color on the cheek
Time Frame: 4 Months
|
Skin colorimetric measurement using a Spectrophotometer (Konica Minolta)
|
4 Months
|
|
Age-related changes in skin melanin on the cheek
Time Frame: 4 Months
|
Colorimetric measurement of skin melanin using a Mexameter MX18 (Courage & Khazaka)
|
4 Months
|
|
Age-related changes in skin elasticity on the cheek and thigh
Time Frame: 4 Months
|
Skin elasticity measurement using a Cutometer (Courage & Khazaka), ElastiMeter (Delfin Technologies), and Dermal Torque Meter (Dia-Stron Limited)
|
4 Months
|
|
Age-related changes in skin thickness on the cheek and thigh
Time Frame: 4 Months
|
Ultrasound imaging using a Dermascan Ultrasound (Cortex Technology)
|
4 Months
|
|
Age-related changes in skin topography on the cheek and thigh
Time Frame: 4 Months
|
Skin topography imaged using a PRIMOS (Canfield Scientific) fringe projection imaging system.
Output measurements from the images will include Ra (average roughness), Rz (average height of roughness), and Rt (maximum height of the roughness profile).
|
4 Months
|
|
Age-related changes in skin topography on the cheek and thigh
Time Frame: 4 Months
|
Skin topography imaged using a DermaTOP (EOTECH) fringe projection imaging system.
Output measurements from the images will include Ra (average roughness), Rz (average height of roughness), and Rt (maximum height of the roughness profile).
|
4 Months
|
|
Age-related changes in skin density on the cheek and thigh
Time Frame: 4 Months
|
Ultrasound imaging using a Dermascan Ultrasound (Cortex Technology)
|
4 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reproducibility and repeatability of the skin hydration measurement on the cheek
Time Frame: 4 Months
|
The reproducibility and repeatability of the tissue dielectric constant measurement using MoistureMeter D (Delfin Technologies) will be determined by repeating the measurement three times by two technicians
|
4 Months
|
|
Reproducibility and repeatability of the skin hydration measurement on the cheek
Time Frame: 4 Months
|
The reproducibility and repeatability of the tissue dielectric constant measurement using a Corneometer (Courage & Khazaka) will be determined by repeating the measurement three times by two technicians
|
4 Months
|
|
Reproducibility and repeatability of the skin barrier function measurement on the cheek
Time Frame: 4 Months
|
The reproducibility and repeatability of the Transepidermal water loss measurement using an AquaFlux AF100 (Biox Systems Ltd) will be determined by repeating the measurement three times by two technicians
|
4 Months
|
|
Reproducibility and repeatability of the skin radiance measurement on the cheek
Time Frame: 4 Months
|
The reproducibility and repeatability of the light reflection using a Skin-Glossymeter GL200 (Courage & Khazaka) will be determined by repeating the measurement three times by two technicians
|
4 Months
|
|
Reproducibility and repeatability of the skin color measurement on the cheek
Time Frame: 4 Months
|
The reproducibility and repeatability of the skin colorimetric measurement using a Spectrophotometer (Konica Minolta) will be determined by repeating the measurement three times by two technicians
|
4 Months
|
|
Reproducibility and repeatability of the skin melanin changes on the cheek
Time Frame: 4 Months
|
The reproducibility and repeatability of the colorimetric measurement of skin melanin using a Mexameter MX18 (Courage & Khazaka) will be determined by repeating the measurement three times by two technicians
|
4 Months
|
|
Reproducibility and repeatability of the changes in skin elasticity on the cheek and thigh
Time Frame: 4 Months
|
The reproducibility and repeatability of the skin elasticity measurement using a Cutometer (Courage & Khazaka), ElastiMeter (Delfin Technologies), and Dermal Torque Meter (Dia-Stron Limited) will be determined by repeating the measurement three times by two technicians
|
4 Months
|
|
Reproducibility and repeatability of the changes in skin thickness and density on the cheek and thigh
Time Frame: 4 Months
|
The reproducibility and repeatability of the measurement of ultrasound imaging using a Dermascan Ultrasound (Cortex Technology) will be determined by repeating the measurement three times by two technicians
|
4 Months
|
|
Reproducibility and repeatability of the changes in skin topography on the cheek
Time Frame: 4 Months
|
The reproducibility and repeatability of the skin topographyusing a PRIMOS (Canfield Scientific) fringe projection imaging system will be determined by repeating the measurement three times by two technicians
|
4 Months
|
|
Reproducibility and repeatability of the changes in skin topography on the cheek
Time Frame: 4 Months
|
The reproducibility and repeatability of the skin topography will be imaged using a DermaTOP (EOTECH) fringe projection imaging system and will be determined by repeating the measurement three times by two technicians
|
4 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Siham Rharbaoui, MD, DERMSCAN - Pharmascan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 18, 2019
Primary Completion (Actual)
July 12, 2019
Study Completion (Actual)
July 12, 2019
Study Registration Dates
First Submitted
January 24, 2019
First Submitted That Met QC Criteria
February 13, 2019
First Posted (Actual)
February 15, 2019
Study Record Updates
Last Update Posted (Actual)
July 17, 2019
Last Update Submitted That Met QC Criteria
July 16, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 2019-602-000
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Age-related Skin Changes
-
AllerganCompletedAge-related Skin ChangesFrance
-
AllerganCompletedAge-related Skin ChangesChina
-
Collagen Research InstituteGELITACompletedAge-related Changes in Skin Appearance and PhysiologyChina
-
University of FloridaNational Institute on Aging (NIA)CompletedEffect of Age-related Changes in the Brain on Walking AbilityUnited States
-
Eunice Kennedy Shriver National Institute of Child...WithdrawnAge-Related Macular Degeneration | Age-Related Macular Changes | Cataract and IOL Surgery | Retinal Photochemistry
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsTerminatedDry Age-related Macular DegenerationUnited States, Germany, United Kingdom, Spain, Poland, Australia, France, Netherlands
-
Innostellar Biotherapeutics Co.,LtdActive, not recruitingNeovascular Age-Related Macular DegenerationChina
-
REGENXBIO Inc.CompletedNeovascular Age-related Macular Degeneration | Wet Age-related Macular DegenerationUnited States
-
Gyroscope Therapeutics LimitedNovartis PharmaceuticalsTerminatedDry Age-related Macular DegenerationUnited States, Germany, United Kingdom, France, Spain, Australia, Poland
-
Notal Vision Inc.CompletedNeovascular Age-related Macular Degeneration | Intermediate Age Related Macular Degeneration (Disorder)United States